George J. Burghel

Nov 16, 2024 | nature.com | Robert Morgan |Bethany Barnes |Helene Schlecht |George J. Burghel |Andrew Clamp |Richard Edmondson | +2 more

AbstractHigh-grade serous ovarian cancer (HGSOC) can be treated with platinum-based neoadjuvant chemotherapy (NACT) and delayed primary surgery (DPS). Histopathological response to NACT can be assessed using Böhm’s chemotherapy response score (CRS). We investigated whether germline BRCA1/2 (gBRCA1/2) genotype associated with omental CRS phenotype.

Dec 29, 2023 | mdpi.com | Robert Morgan |George J. Burghel |Helene Schlecht |Andrew Clamp

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.